- Home
- HP vs TVTX Comparison
HP vs TVTX Comparison
Compare HP & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HP
- TVTX
- Stock Information
- Founded
- HP 1920
- TVTX 2008
- Country
- HP United States
- TVTX United States
- Employees
- HP N/A
- TVTX N/A
- Industry
- HP Oil & Gas Production
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- HP Energy
- TVTX Health Care
- Exchange
- HP Nasdaq
- TVTX Nasdaq
- Market Cap
- HP 1.6B
- TVTX 1.5B
- IPO Year
- HP N/A
- TVTX N/A
- Fundamental
- Price
- HP $17.69
- TVTX $18.82
- Analyst Decision
- HP Hold
- TVTX Strong Buy
- Analyst Count
- HP 10
- TVTX 16
- Target Price
- HP $21.67
- TVTX $33.40
- AVG Volume (30 Days)
- HP 2.4M
- TVTX 1.5M
- Earning Date
- HP 08-06-2025
- TVTX 08-06-2025
- Dividend Yield
- HP 5.65%
- TVTX N/A
- EPS Growth
- HP N/A
- TVTX N/A
- EPS
- HP N/A
- TVTX N/A
- Revenue
- HP $3,428,058,000.00
- TVTX $333,865,000.00
- Revenue This Year
- HP $36.76
- TVTX $71.61
- Revenue Next Year
- HP $4.08
- TVTX $43.45
- P/E Ratio
- HP N/A
- TVTX N/A
- Revenue Growth
- HP 25.92
- TVTX 87.94
- 52 Week Low
- HP $14.65
- TVTX $8.46
- 52 Week High
- HP $37.46
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- HP 57.63
- TVTX 74.85
- Support Level
- HP $17.43
- TVTX $15.60
- Resistance Level
- HP $18.43
- TVTX $17.46
- Average True Range (ATR)
- HP 0.81
- TVTX 0.83
- MACD
- HP 0.23
- TVTX 0.26
- Stochastic Oscillator
- HP 77.30
- TVTX 98.44
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.